Maintenance fees coming due
6 maintenance fees come due in the 12 months from Nov 17, 2026, the next on Jun 5, 2027. Unpaid by Dec 6, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,833,121 | Composition and Method for Treating Neurological Disease In force Fee due Jun 5, 2027 Lapses if unpaid Dec 6, 2027 · High confidence | Adamas Pharmaceuticals, Inc. | In force | Jun 5, 2027 | Dec 6, 2027 | High confidence | |
| US 10,500,170 | Composition and Method for Treating Neurological Disease In force Fee due Jun 10, 2027 Lapses if unpaid Dec 10, 2027 · High confidence | Adamas Pharmaceuticals, Inc. | In force | Jun 10, 2027 | Dec 10, 2027 | High confidence | |
| US 10,500,171 | Composition and Method for Treating Neurological Disease In force Fee due Jun 10, 2027 Lapses if unpaid Dec 10, 2027 · High confidence | Adamas Pharmaceuticals, Inc. | In force | Jun 10, 2027 | Dec 10, 2027 | High confidence | |
| US 10,500,172 | Composition and Method for Treating Neurological Disease In force Fee due Jun 10, 2027 Lapses if unpaid Dec 10, 2027 · High confidence | Adamas Pharmaceuticals, Inc. | In force | Jun 10, 2027 | Dec 10, 2027 | High confidence | |
| US 10,512,617 | Composition and Method for Treating Neurological Disease In force Fee due Jun 24, 2027 Lapses if unpaid Dec 27, 2027 · High confidence | Adamas Pharmaceuticals, Inc. | In force | Jun 24, 2027 | Dec 27, 2027 | High confidence | |
| US 11,890,261 | Composition and Method for Treating Neurological Disease In force Fee due Aug 6, 2027 Lapses if unpaid Feb 7, 2028 · High confidence | Adamas Pharmaceuticals, Inc. | In force | Aug 6, 2027 | Feb 7, 2028 | High confidence |
6 of 6 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.